HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rasmus P Clausen Selected Research

Tiagabine (Gabitril)

7/2020Pharmacological Characterization of a Betaine/GABA Transporter 1 (BGT1) Inhibitor Displaying an Unusual Biphasic Inhibition Profile and Anti-seizure Effects.
1/2018Inhibition of GABA transporters fails to afford significant protection following focal cerebral ischemia.
7/2011Selective GABA transporter inhibitors tiagabine and EF1502 exhibit mechanistic differences in their ability to modulate the ataxia and anticonvulsant action of the extrasynaptic GABA(A) receptor agonist gaboxadol.
5/2009Synaptic and extrasynaptic GABA transporters as targets for anti-epileptic drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rasmus P Clausen Research Topics

Disease

4Seizures (Absence Seizure)
07/2020 - 05/2009
4Neoplasms (Cancer)
09/2014 - 06/2011
3Nervous System Diseases (Neurological Disorders)
01/2022 - 10/2014
3Epilepsy (Aura)
07/2020 - 08/2013
3Narcolepsy
08/2015 - 12/2008
2Brain Ischemia (Cerebral Ischemia)
01/2021 - 01/2018
2Alcoholism (Alcohol Abuse)
08/2015 - 08/2012
2Partial Epilepsies (Epilepsy, Partial)
05/2009 - 02/2005
1Mental Disorders (Mental Disorder)
11/2012
1X-Linked Mental Retardation (Mental Retardation, X Linked)
09/2012
1Breast Neoplasms (Breast Cancer)
09/2012
1Ataxia (Dyssynergia)
07/2011
1Parkinson Disease (Parkinson's Disease)
11/2010
1Reflex Epilepsy (Photosensitive Epilepsy)
05/2009
1Brain Diseases (Brain Disorder)
10/2008

Drug/Important Bio-Agent (IBA)

6GABA Plasma Membrane Transport ProteinsIBA
07/2020 - 05/2009
5Pharmaceutical PreparationsIBA
08/2015 - 12/2008
4EF1502IBA
07/2020 - 02/2005
4Tiagabine (Gabitril)FDA Link
07/2020 - 05/2009
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2022 - 10/2008
3Proteins (Proteins, Gene)FDA Link
10/2014 - 10/2008
3Histone DemethylasesIBA
09/2014 - 06/2011
2Betaine (C.B.B.)FDA Link
07/2020 - 08/2013
2gamma-Aminobutyric Acid (GABA)IBA
07/2020 - 07/2011
2Aminobutyrates (Aminobutyric Acid)IBA
07/2020 - 10/2014
2EnzymesIBA
09/2012 - 06/2011
2Anticonvulsants (Antiepileptic Drugs)IBA
07/2011 - 02/2005
13-hydroxycyclopent-1-enecarboxylic acidIBA
01/2021
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2021
1Neuroprotective AgentsIBA
01/2018
1AcidsIBA
08/2015
1Illicit Drugs (Recreational Drugs)IBA
08/2015
1Membrane Transport Proteins (Biological Pump)IBA
10/2014
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
11/2012
1Therapeutic UsesIBA
08/2012
1Neurotransmitter Agents (Neurotransmitter)IBA
08/2012
1nipecotic acidIBA
07/2011
1gaboxadol (THIP)IBA
07/2011
1GABA-A Receptor AgonistsIBA
07/2011
1LigandsIBA
06/2011
1Selegiline (E250)FDA LinkGeneric
11/2010
1NitrogenIBA
11/2010
1Monoamine Oxidase (MAO)IBA
11/2010
1ConvulsantsIBA
05/2009